Submitted by jwr@option4.com on Sat, 07/17/2010 - 20:03
Clinical Trials Evaluating the Role of Sentinel Node Resection (SNR) in Early-Stage Breast Cancer
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from July 20, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from presentations at ASCO 2010 and transcribed comments from recent interviews with Kathy D Miller, MD (6/11/10) and Eric P Winer, MD (7/6/10)
Krag DN et al. Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients. Proc ASCO 2010;Abstract LBA505.
Cote R et al. ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. Proc ASCO 2010;Abstract CRA504.
Guiliano AE et al. ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node. Proc ASCO 2010;Abstract CRA506.